๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 51 Guangzhou 16 Changchun 10 Shanghai 9 Fuzhou 8
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing51 Guangzhou16 Changchun10 Shanghai9 Fuzhou8
All 121 locations
Target enrolment
to

Trials with a site in Guangzhou

16 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window
NCT07606807Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
750
Guangzhou
2026-08-01
Not yet open
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic Stroke
NCT07604298Acute Ischemic Stroke
Nanfang Hospital, Southern Medical University
Observational
2,000
Guangzhou
2026-07-01
Not yet open
Butylphthalide for Brain Edema After Endovascular Treatment
NCT07528456Acute Ischemic Stroke
Nanfang Hospital, Southern Medical University
Phase 4
100
Dongguan, Guangzhou, Heyuan, Qingyuan, Shaoguan, Haikou, Ganzhou
2026-04-01
Not yet open
Extended Time Window Intravenous Thrombolysis Registry for Acute Ischemic Stroke
NCT07536074Stroke, Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
3,000
Guangzhou, Guankou
2026-04
Not yet open
Extended Time Window Intravenous Tenecteplase Thrombolysis Registry for Acute Ischemic Stroke
NCT07536165Stroke, Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
3,000
Guangzhou, Guankou
2026-04
Not yet open
Intravenous Tirofiban After Delayed Thrombolysis in Stroke
NCT07111806Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
852
Guangzhou
2025-12-01
Active, closed
HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
NCT07233070Acute Ischemic Stroke
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
210
Guangzhou, Linyi
2025-10-31
Recruiting
OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion
NCT07137832Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
530
Guangzhou
2025-10-09
Not yet open
PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy
NCT07174375Acute Ischemic Stroke
Nanfang Hospital, Southern Medical University
Phase 2/3
478
Fuzhou, Dongguan, Guangzhou, Heyuan, Hengzhou, Haikou, Ganzhou
2025-09-15
Recruiting
Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users
NCT07092709Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
912
Guangzhou
2025-08-14
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
NCT06990867Acute Ischemic Stroke
Corxel Pharmaceuticals
Phase 2/3
740
Baotou, Beijing, Changchun, Guangzhou, Harbin, Kaili, Linfen, Nanyang
2025-05-15
Not yet open
Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke
NCT06870448Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
1,614
Guangzhou
2025-04
Recruiting
To Assess the Effectiveness and Safety of Catheter-based Focal Intracranial Hypothermia Combined with Endovascular Reperfusion Therapy for Patients with Acute Anterior Circulation Large Artery Occlusion
NCT06758609Acute Cerebrovascular Accident, Acute Ischemic Stroke, Internal Carotid Artery, Middle Cerebral Artery Occlusion
Guangdong Second Provincial General Hospital
Not applicable
262
Guangzhou
2024-12-01
Not yet open
Efficacy and Safety of Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke Combined With Type 2 Diabetes Mellitus
NCT06085378Acute Ischemic Stroke, Type 2 Diabetes
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
630
Guangzhou
2024-01-01
Not yet open
Association of Prophylactic Use of Stress Ulcer Drugs and Clinical Outcomes in Patients With Acute Anterior Circulation Thrombectomy
NCT05845372Acute Ischemic Stroke
Nanfang Hospital, Southern Medical University
Observational
2,592
Fuzhou, Dongguan, Guangzhou, Heyuan, Huizhou, Haikou, Changsha, Hengyang
2023-05-01
Recruiting
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
300
Beijing, Guangzhou, Luoyang, Hengshui, Daqing, Wuhan, Baotou, Huai'an
2023-04-06
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Guangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Guangzhou?

6 of the 16 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 9 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Guangzhou), 16 studies
PhaseStudiesRecruitingShare
Phase 35331.3%
Observational4025%
Not applicable2112.5%
Phase 22112.5%
Phase 2/32112.5%
Phase 4106.3%

Most active sponsors

Lead sponsors with the most studies (Guangzhou)
Lead sponsorStudiesRecruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University73
Nanfang Hospital, Southern Medical University40
Corxel Pharmaceuticals11
First Affiliated Hospital, Sun Yat-Sen University10
Fujian Shengdi Pharmaceutical Co., Ltd.10
Guangdong Second Provincial General Hospital11
Shanghai Pharmaceuticals Holding Co., Ltd11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.